首页 | 本学科首页   官方微博 | 高级检索  
     


Amorphous drug nanosuspensions. 2. Experimental determination of bulk monomer concentrations
Authors:Lindfors Lennart  Forssén Sara  Skantze Pia  Skantze Urban  Zackrisson Anna  Olsson Ulf
Affiliation:Pharmaceutical and Analytical R&D, AstraZeneca R&D M?lndal, Sweden. lennart.lindfors@astrazeneca.com
Abstract:A simple turbidimetric method was developed to measure the bulk concentration of drug in nanosuspensions. The bulk concentrations measured were in the range from 1 microM to 1 mM. The accuracy of the method was checked by determination of the bulk concentration of crystalline nanosuspensions, i.e., the crystalline solubility, which compared favorably to solubilities measured by a conventional method. Results obtained for amorphous nanosuspensions agreed with predictions using a theory describing the relative solubility between a supercooled liquid and a crystal. Further, it was found that the bulk concentration in Ostwald ripening inhibited amorphous nanosuspensions and could be lowered by incorporation of higher amounts of the inhibitor, in agreement with predictions using the Bragg-Williams theory of nonideal solutions.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号